Medical Information in Asia-Pacific

Access 25 years of world-class medical information services in Asia-Pacific

Why Choose ProPharma?

We’re proud to offer over 25 years of expertise in delivering Medical Information services. Our team of experts can ensure the safe and effective use of your healthcare products, while maintaining compliance with local regulatory environments. Regardless of your location, you’ll receive the same, consistent high-level of service.

Woman in lab coat wearing headset stethoscope typing on laptop

Consistent, High-Quality Services To Meet Your Needs

If you’re a global company, looking to strengthen your presence in the Asia-Pacific and Japanese market, or a company headquartered in the region, our Medical Information services are customizable, so can be tailored to your business’ size and needs.

customer-service-professional-wearing-headset-asking-coworker-a-question-ss-2149603273

Contact Center Support

With our scalable contact centers across the region, with optional 24-7 availability, we offer multilingual support from native-speaking medical professionals. This enables us to respond to patients, healthcare professionals, and other inquirers in a swift manner that is consistent with both country regulations and license and the inquirer's local cultural and communication etiquette. In Asia-Pacific, our experts can provide support in Japanese, Cantonese, Korean, Thai, Mandarin, Vietnamese, Filipino, Hindi, Indonesian, and English.
 
Healthcare worker showing patient something

Patient Support Services

We offer solutions to support patients, caregivers, and healthcare professionals to initiate and sustain therapies, helping them to overcome barriers and achieve better health outcomes. Our services include disease state education, for better understanding and informed decision-making, drug administration assistance, adherence outreach, patient helplines, caregiver support, concierge services, and connections to advocacy programs. 

 

Healthcare professional writing

Medical Writing

Our team of expert writers, editors, and quality reviewers understand the importance of providing clear, concise text for your clinical, scientific, and regulatory needs, in addition to ensuring your content remains up-to-date and compliant. With bilingual, native-speaking medical professionals, we also ensure that content is consistent with local requirements, culture, and communication styles. We can create or translate documents in more than 35 languages globally, including Japanese, Cantonese, Korean, Thai, Mandarin, Vietnamese, Filipino, Hindi, Indonesian, and English.

Expertise Across Asia-Pacific

With expert teams located across Asia-Pacific, we ensure local needs and requirements are not only covered, but also respected.

India

We have a fully integrated Medical Information (MI) Contact Center based in Hyderabad, India that is strategically positioned to offer our clients the ability to have the MI service options they’ve come to know from ProPharma, however at competitive low costs, while maintaining a high level of quality and customer excellence. India is a direct extension of the teams they support in US, EU, and APAC regions and can support local service hours.

Philippines

We have a fully integrated Medical Information (MI) Contact Center based in Manilla, Philippines that is strategically positioned to offer our clients competitively priced solutions, while providing piece of mind that their services are supported by experienced medical professionals with excellent English language skill, and years of relevant experience. Philippines is a direct extension of the teams they support in regions such as APAC, US, EU, supporting the local service hours.

Japan

We have a fully integrated Medical Information (MI) Contact Center based in Tokyo, Japan. Our experts, who are qualified Japanese healthcare professionals, work with local GVP knowledge, so they can identify and respond to adverse events in accordance to the guidelines. The team can also provide support using communication channels that work for you, including SMS, SNS, email, chat, and phone calls.

Korea

As our expert team are native Korean speakers, they understand the importance of cultural communication etiquette. This includes the hierarchical structure in Korean businesses, such as the significance of respecting seniority, and they also keep on top of local social issues that may arise and cause disruptions. Our teams also have thorough knowledge of the Personal Information Protection Act (PIPA), ensuring they adhere to the requirements of the act.

News & Insights

FDA Releases Final ICH M13A Guidance Document

December 10, 2024

FDA Releases Final ICH M13A Guidance Document

FDA recommendations for conducting BE studies, efficiency improvements in global drug development, and how ProPharma can assist with your regulatory needs.

The Evolving Landscape of Quality Management Systems in the Life Sciences Industry

December 9, 2024

The Evolving Landscape of Quality Management Systems in the Life Sciences Industry

Discover the evolving landscape of Quality Management Systems in the life sciences industry and how to navigate modern regulatory challenges.

Pre-Approval Inspection (PAI) Readiness is Easy, Right?

December 5, 2024

Pre-Approval Inspection (PAI) Readiness is Easy, Right?

Ensure your product's success with ProPharma's expert guidance on PAI readiness, from remediation tasks to regulatory filing support.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Award Arrow Next Award Arrow
FDA Releases Final ICH M13A Guidance Document

December 10, 2024

FDA Releases Final ICH M13A Guidance Document

FDA recommendations for conducting BE studies, efficiency improvements in global drug development, and how ProPharma can assist with your regulatory needs.

The Evolving Landscape of Quality Management Systems in the Life Sciences Industry

December 9, 2024

The Evolving Landscape of Quality Management Systems in the Life Sciences Industry

Discover the evolving landscape of Quality Management Systems in the life sciences industry and how to navigate modern regulatory challenges.

Pre-Approval Inspection (PAI) Readiness is Easy, Right?

December 5, 2024

Pre-Approval Inspection (PAI) Readiness is Easy, Right?

Ensure your product's success with ProPharma's expert guidance on PAI readiness, from remediation tasks to regulatory filing support.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow